Pedro Mateu-Gelabert, PhD
CUNY Graduate School of Public Health and Health Policy - Associate Professor
PhD, Sociology, New York University
BA, Sociology, Universidad Complutense, Madrid
Research Interests
Epidemiology of drug use, HIV/HCV prevention, Prescription opioid misuse, Overdose, HIV in Latin America, Urban ethnography
Pedro Mateu-Gelabert is an Associate Professor at the CUNY Graduate School of Public Health and Health Policy and a sociologist with over 20 years of research experience in New York City and internationally. His research spans the epidemiology of drug use, urban studies, crime, immigration, social networks, and HIV/Hepatitis C prevention. He has more than 50 peer-reviewed publications and has been guest lecturer in numerous national and international forums including University of Chicago, Columbia University, Beth Israel Medical Center, Colombian Ministry of Health, Rio de Janeiro Office of Public Safety, and Office of Human Rights in San José (Costa Rica). Dr. Mateu-Gelabert has collaborated with various interdisciplinary research teams, including the New York City Department of Health and Mental Hygiene (NYCDOHMH), Weill Cornell Medical College, and Beth Israel Medical Center. He has worked on international projects in multiple countries including Colombia (Emerging heroin markets leading to HIV epidemics among young injectors), Spain (HCV prevention among injection drug users) and Ukraine (HIV treatment access and care cascade for people who inject drugs).
Principal Investigator, Accessible Care Intervention for Engaging People Who Inject Illicit Drugs (PWID) in Hepatitis C Care. Active
Principal Investigator, Staying Safe Intervention: Preventing HCV Among Youth Opioid Injectors. Active
Principal Investigator, HIV, HCV and STI Risk Associated with Nonmedical Use of Prescription Opioids. Completed
Principal Investigator, Staying Safe: Training IDUs in Strategies to Avoid HIV and HCV Infection. Completed


Katzman C, Mateu-Gelabert P, Kapadia SN, Eckhardt BJ (2019).
Contact tracing for hepatitis C: The case for novel screening strategies as we strive for viral elimination
International Journal of Drug Policy, 72, 33-39. doi: 10.1016/j.drugpo.2019.04.003. PMCID: PMC6717536.

Friedman SR, Pouget ER, Sandoval M, Nikolopoulos GK, Mateu-Gelabert P, Rossi D, Auerbach JD (2019).
New measures for research on men who have sex with men and for at-risk heterosexuals: Tools to study links between structural interventions or large-scale social change and HIV risk behaviors, service use, and infection
AIDS and Behavior [Epub 2019 Jul 11]. doi: 10.1007/s10461-019-02582-w.

Palamar JJ, Le A, Mateu-Gelabert P (2019).
Perceived risk of heroin in relation to other drug use in a representative US sample
Journal of Psychoactive Drugs [Epub 2019 Jun 22]. doi: 10.1080/02791072.2019.1632506.

Palamar JJ, Le A, Guarino H, Mateu-Gelabert P (2019).
A comparison of the utility of urine- and hair testing in detecting self-reported drug use among young adult opioid users
Drug and Alcohol Dependence, 200, 161-167. doi: 10.1016/j.drugalcdep.2019.04.008. PMCID: PMC6588496.

Meylakhs P, Friedman SR, Meylakhs A, Mateu-Gelabert P, Ompad DC, Alieva A, Dmitrieva A (2019).
A new generation of drug users in St. Petersburg, Russia? HIV, HCV, and overdose risks in a mixed-methods pilot study of young hard drug users
AIDS and Behavior [Epub 2019 Apr 11]. doi: 10.1007/s10461-019-02489-6.

Dr. Mateu-Gelabert's Google Scholar Profile
Selected Press